抗糖尿病薬の世界市場 2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Anti-diabetic Medication Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D0804-14744 • 出版社/出版日：GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、100ページ • 納品方法：Eメール • 産業分類：医薬品・治療

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、抗糖尿病薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。抗糖尿病薬の種類別市場規模（経口、注射、その他）、用途別市場規模（糖尿病予防・治療、肥満治療、心血管保護、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Merck Sharp & Dohme、Uni-Bio Group、Huadong Medicine、Lilly、Luye、Novo Nordisk、Oddway International、Bayer ・地域別グローバル市場分析 2015年-2020年 ・抗糖尿病薬の北米市場（アメリカ、カナダ、メキシコ） ・抗糖尿病薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・抗糖尿病薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・抗糖尿病薬の南米市場（ブラジル、アルゼンチン） ・抗糖尿病薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：経口、注射、その他 ・用途別分析：糖尿病予防・治療、肥満治療、心血管保護、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The Anti-diabetic Medication market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The most likely (base case) scenario is that the global Anti-diabetic Medication sales will be xx in 2020 from Anti-diabetic Medication million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Anti-diabetic Medication market size is expected to grow at xx% or more annually for the next five years.

This report also researches and evaluates the impact of Covid-19 outbreak on the Anti-diabetic Medication industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Anti-diabetic Medication and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Market segmentation
Anti-diabetic Medication market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Anti-diabetic Medication market has been segmented into:
Oral
Injection
Other

By Application, Anti-diabetic Medication has been segmented into:
Prevent and Treatment Diabetes
Obesity Treatment
Cardiovascular Protection
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Anti-diabetic Medication market presented in the report. This section sheds light on the sales growth of different regional and country-level Anti-diabetic Medication markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Anti-diabetic Medication market.

The report offers in-depth assessment of the growth and other aspects of the Anti-diabetic Medication market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Anti-diabetic Medication Market Share Analysis
Anti-diabetic Medication competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Anti-diabetic Medication sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Anti-diabetic Medication sales, revenue and market share for each player covered in this report.

The major players covered in Anti-diabetic Medication are:
Merck Sharp & Dohme
Uni-Bio Group
Huadong Medicine
Lilly
Luye
Novo Nordisk
Oddway International
Bayer

レポート目次

---

1 Anti-diabetic Medication Market Overview
1.1 Product Overview and Scope of Anti-diabetic Medication
1.2 Classification of Anti-diabetic Medication by Type
1.2.1 Global Anti-diabetic Medication Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Anti-diabetic Medication Revenue Market Share by Type in 2019
1.2.3 Oral
1.2.4 Injection
1.2.5 Other
1.3 Global Anti-diabetic Medication Market by Application
1.3.1 Overview: Global Anti-diabetic Medication Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Prevent and Treatment Diabetes
1.3.3 Obesity Treatment
1.3.4 Cardiovascular Protection
1.3.5 Other
1.4 Global Anti-diabetic Medication Market by Regions
1.4.1 Global Anti-diabetic Medication Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Anti-diabetic Medication (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Anti-diabetic Medication Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Anti-diabetic Medication Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Anti-diabetic Medication Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Anti-diabetic Medication Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Anti-diabetic Medication Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Anti-diabetic Medication Industry Impact
1.5.1 COVID-19 Potential Implications for the Anti-diabetic Medication
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Anti-diabetic Medication
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Merck Sharp & Dohme
2.1.1 Merck Sharp & Dohme Details
2.1.2 Merck Sharp & Dohme Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck Sharp & Dohme SWOT Analysis
2.1.4 Merck Sharp & Dohme Product and Services
2.1.5 Merck Sharp & Dohme Anti-diabetic Medication Revenue, Gross Margin and Market Share (2018-2019)
2.2 Uni-Bio Group
2.2.1 Uni-Bio Group Details
2.2.2 Uni-Bio Group Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Uni-Bio Group SWOT Analysis
2.2.4 Uni-Bio Group Product and Services
2.2.5 Uni-Bio Group Anti-diabetic Medication Revenue, Gross Margin and Market Share (2018-2019)
2.3 Huadong Medicine
2.3.1 Huadong Medicine Details
2.3.2 Huadong Medicine Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Huadong Medicine SWOT Analysis
2.3.4 Huadong Medicine Product and Services
2.3.5 Huadong Medicine Anti-diabetic Medication Revenue, Gross Margin and Market Share (2018-2019)
2.4 Lilly
2.4.1 Lilly Details
2.4.2 Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Lilly SWOT Analysis
2.4.4 Lilly Product and Services
2.4.5 Lilly Anti-diabetic Medication Revenue, Gross Margin and Market Share (2018-2019)
2.5 Luye
2.5.1 Luye Details
2.5.2 Luye Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Luye SWOT Analysis
2.5.4 Luye Product and Services
2.5.5 Luye Anti-diabetic Medication Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novo Nordisk
2.6.1 Novo Nordisk Details
2.6.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Novo Nordisk SWOT Analysis
2.6.4 Novo Nordisk Product and Services
2.6.5 Novo Nordisk Anti-diabetic Medication Revenue, Gross Margin and Market Share (2018-2019)
2.7 Oddway International
2.7.1 Oddway International Details
2.7.2 Oddway International Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Oddway International SWOT Analysis
2.7.4 Oddway International Product and Services
2.7.5 Oddway International Anti-diabetic Medication Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bayer
2.8.1 Bayer Details
2.8.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Bayer SWOT Analysis
2.8.4 Bayer Product and Services
2.8.5 Bayer Anti-diabetic Medication Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Anti-diabetic Medication Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Anti-diabetic Medication Players Market Share
3.2.2 Top 10 Anti-diabetic Medication Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Anti-diabetic Medication Revenue and Market Share by Regions
4.2 North America Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
4.3 Europe Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
4.5 South America Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
5 North America Anti-diabetic Medication Revenue by Countries
5.1 North America Anti-diabetic Medication Revenue by Countries (2015-2020)
5.2 USA Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
5.3 Canada Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
5.4 Mexico Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
6 Europe Anti-diabetic Medication Revenue by Countries
6.1 Europe Anti-diabetic Medication Revenue by Countries (2015-2020)
6.2 Germany Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
6.3 UK Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
6.4 France Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
6.5 Russia Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
6.6 Italy Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Anti-diabetic Medication Revenue by Countries
7.1 Asia-Pacific Anti-diabetic Medication Revenue by Countries (2015-2020)
7.2 China Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
7.3 Japan Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
7.4 Korea Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
7.5 India Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
8 South America Anti-diabetic Medication Revenue by Countries
8.1 South America Anti-diabetic Medication Revenue by Countries (2015-2020)
8.2 Brazil Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
8.3 Argentina Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Anti-diabetic Medication by Countries
9.1 Middle East & Africa Anti-diabetic Medication Revenue by Countries (2015-2020)
9.2 Saudi Arabia Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
9.3 UAE Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
9.4 Egypt Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
9.5 South Africa Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Anti-diabetic Medication Revenue and Market Share by Type (2015-2020)
10.2 Global Anti-diabetic Medication Market Forecast by Type (2019-2024)
10.3 Oral Revenue Growth Rate (2015-2025)
10.4 Injection Revenue Growth Rate (2015-2025)
10.5 Other Revenue Growth Rate (2015-2025)
11 Global Anti-diabetic Medication Market Segment by Application
11.1 Global Anti-diabetic Medication Revenue Market Share by Application (2015-2020)
11.2 Anti-diabetic Medication Market Forecast by Application (2019-2024)
11.3 Prevent and Treatment Diabetes Revenue Growth (2015-2020)
11.4 Obesity Treatment Revenue Growth (2015-2020)
11.5 Cardiovascular Protection Revenue Growth (2015-2020)
11.6 Other Revenue Growth (2015-2020)
12 Global Anti-diabetic Medication Market Size Forecast (2021-2025)
12.1 Global Anti-diabetic Medication Market Size Forecast (2021-2025)
12.2 Global Anti-diabetic Medication Market Forecast by Regions (2021-2025)
12.3 North America Anti-diabetic Medication Revenue Market Forecast (2021-2025)
12.4 Europe Anti-diabetic Medication Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Anti-diabetic Medication Revenue Market Forecast (2021-2025)
12.6 South America Anti-diabetic Medication Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Anti-diabetic Medication Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Anti-diabetic Medication Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Anti-diabetic Medication by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Anti-diabetic Medication Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Anti-diabetic Medication Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Anti-diabetic Medication Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Merck Sharp & Dohme Corporate Information, Location and Competitors
Table 7. Merck Sharp & Dohme Anti-diabetic Medication Major Business
Table 8. Merck Sharp & Dohme Anti-diabetic Medication Total Revenue (USD Million) (2017-2018)
Table 9. Merck Sharp & Dohme SWOT Analysis
Table 10. Merck Sharp & Dohme Anti-diabetic Medication Product and Solutions
Table 11. Merck Sharp & Dohme Anti-diabetic Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Uni-Bio Group Corporate Information, Location and Competitors
Table 13. Uni-Bio Group Anti-diabetic Medication Major Business
Table 14. Uni-Bio Group Anti-diabetic Medication Total Revenue (USD Million) (2018-2019)
Table 15. Uni-Bio Group SWOT Analysis
Table 16. Uni-Bio Group Anti-diabetic Medication Product and Solutions
Table 17. Uni-Bio Group Anti-diabetic Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Huadong Medicine Corporate Information, Location and Competitors
Table 19. Huadong Medicine Anti-diabetic Medication Major Business
Table 20. Huadong Medicine Anti-diabetic Medication Total Revenue (USD Million) (2017-2018)
Table 21. Huadong Medicine SWOT Analysis
Table 22. Huadong Medicine Anti-diabetic Medication Product and Solutions
Table 23. Huadong Medicine Anti-diabetic Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Lilly Corporate Information, Location and Competitors
Table 25. Lilly Anti-diabetic Medication Major Business
Table 26. Lilly Anti-diabetic Medication Total Revenue (USD Million) (2017-2018)
Table 27. Lilly SWOT Analysis
Table 28. Lilly Anti-diabetic Medication Product and Solutions
Table 29. Lilly Anti-diabetic Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Luye Corporate Information, Location and Competitors
Table 31. Luye Anti-diabetic Medication Major Business
Table 32. Luye Anti-diabetic Medication Total Revenue (USD Million) (2017-2018)
Table 33. Luye SWOT Analysis
Table 34. Luye Anti-diabetic Medication Product and Solutions
Table 35. Luye Anti-diabetic Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Novo Nordisk Corporate Information, Location and Competitors
Table 37. Novo Nordisk Anti-diabetic Medication Major Business
Table 38. Novo Nordisk Anti-diabetic Medication Total Revenue (USD Million) (2017-2018)
Table 39. Novo Nordisk SWOT Analysis
Table 40. Novo Nordisk Anti-diabetic Medication Product and Solutions
Table 41. Novo Nordisk Anti-diabetic Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Oddway International Corporate Information, Location and Competitors
Table 43. Oddway International Anti-diabetic Medication Major Business
Table 44. Oddway International Anti-diabetic Medication Total Revenue (USD Million) (2017-2018)
Table 45. Oddway International SWOT Analysis
Table 46. Oddway International Anti-diabetic Medication Product and Solutions
Table 47. Oddway International Anti-diabetic Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Bayer Corporate Information, Location and Competitors
Table 49. Bayer Anti-diabetic Medication Major Business
Table 50. Bayer Anti-diabetic Medication Total Revenue (USD Million) (2017-2018)
Table 51. Bayer SWOT Analysis
Table 52. Bayer Anti-diabetic Medication Product and Solutions
Table 53. Bayer Anti-diabetic Medication Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Global Anti-diabetic Medication Revenue (Million USD) by Players (2015-2020)
Table 55. Global Anti-diabetic Medication Revenue Share by Players (2015-2020)
Table 56. Global Anti-diabetic Medication Revenue (Million USD) by Regions (2015-2020)
Table 57. Global Anti-diabetic Medication Revenue Market Share by Regions (2015-2020)
Table 58. North America Anti-diabetic Medication Revenue by Countries (2015-2020)
Table 59. North America Anti-diabetic Medication Revenue Market Share by Countries (2015-2020)
Table 60. Europe Anti-diabetic Medication Revenue (Million USD) by Countries (2015-2020)
Table 61. Asia-Pacific Anti-diabetic Medication Revenue (Million USD) by Countries (2015-2020)
Table 62. South America Anti-diabetic Medication Revenue by Countries (2015-2020)
Table 63. South America Anti-diabetic Medication Revenue Market Share by Countries (2015-2020)
Table 64. Middle East and Africa Anti-diabetic Medication Revenue (Million USD) by Countries (2015-2020)
Table 65. Middle East and Africa Anti-diabetic Medication Revenue Market Share by Countries (2015-2020)
Table 66. Global Anti-diabetic Medication Revenue (Million USD) by Type (2015-2020)
Table 67. Global Anti-diabetic Medication Revenue Share by Type (2015-2020)
Table 68. Global Anti-diabetic Medication Revenue Forecast by Type (2021-2025)
Table 69. Global Anti-diabetic Medication Revenue by Application (2015-2020)
Table 70. Global Anti-diabetic Medication Revenue Share by Application (2015-2020)
Table 71. Global Anti-diabetic Medication Revenue Forecast by Application (2021-2025)
Table 72. Global Anti-diabetic Medication Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Anti-diabetic Medication Picture
Figure 2. Global Anti-diabetic Medication Revenue Market Share by Type in 2019
Figure 3. Oral Picture
Figure 4. Injection Picture
Figure 5. Other Picture
Figure 6. Anti-diabetic Medication Revenue Market Share by Application in 2019
Figure 7. Prevent and Treatment Diabetes Picture
Figure 8. Obesity Treatment Picture
Figure 9. Cardiovascular Protection Picture
Figure 10. Other Picture
Figure 11. Global Anti-diabetic Medication Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Anti-diabetic Medication Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Anti-diabetic Medication Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Anti-diabetic Medication Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Anti-diabetic Medication Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Anti-diabetic Medication Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Anti-diabetic Medication Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Anti-diabetic Medication Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Anti-diabetic Medication Revenue Market Share in 2019
Figure 20. Global Top 10 Players Anti-diabetic Medication Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Anti-diabetic Medication Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Anti-diabetic Medication Revenue Market Share by Regions (2015-2020)
Figure 24. Global Anti-diabetic Medication Revenue Market Share by Regions in 2018
Figure 25. North America Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
Figure 26. Europe Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
Figure 28. South America Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
Figure 30. North America Anti-diabetic Medication Revenue Market Share by Countries (2015-2020)
Figure 31. North America Anti-diabetic Medication Revenue Market Share by Countries in 2019
Figure 32. USA Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
Figure 33. Canada Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
Figure 35. Europe Anti-diabetic Medication Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Anti-diabetic Medication Revenue Market Share by Countries in 2019
Figure 37. Germany Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
Figure 38. UK Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
Figure 39. France Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
Figure 40. Russia Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
Figure 41. Italy Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Anti-diabetic Medication Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Anti-diabetic Medication Revenue Market Share by Countries in 2019
Figure 44. China Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
Figure 45. Japan Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
Figure 46. Korea Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
Figure 47. India Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
Figure 49. South America Anti-diabetic Medication Revenue Market Share by Countries (2015-2020)
Figure 50. South America Anti-diabetic Medication Revenue Market Share by Countries in 2019
Figure 51. Brazil Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Anti-diabetic Medication Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Anti-diabetic Medication Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
Figure 56. UAE Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Anti-diabetic Medication Revenue and Growth Rate (2015-2020)
Figure 59. Global Anti-diabetic Medication Revenue Share by Type (2015-2020)
Figure 60. Global Anti-diabetic Medication Revenue Share by Type in 2019
Figure 61. Global Anti-diabetic Medication Market Share Forecast by Type (2021-2025)
Figure 62. Global Oral Revenue Growth Rate (2015-2020)
Figure 63. Global Injection Revenue Growth Rate (2015-2020)
Figure 64. Global Other Revenue Growth Rate (2015-2020)
Figure 65. Global Anti-diabetic Medication Revenue Share by Application (2015-2020)
Figure 66. Global Anti-diabetic Medication Revenue Share by Application in 2019
Figure 67. Global Anti-diabetic Medication Market Share Forecast by Application (2021-2025)
Figure 68. Global Prevent and Treatment Diabetes Revenue Growth Rate (2015-2020)
Figure 69. Global Obesity Treatment Revenue Growth Rate (2015-2020)
Figure 70. Global Cardiovascular Protection Revenue Growth Rate (2015-2020)
Figure 71. Global Other Revenue Growth Rate (2015-2020)
Figure 72. Global Anti-diabetic Medication Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Anti-diabetic Medication Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Anti-diabetic Medication Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Anti-diabetic Medication Revenue Market Forecast (2021-2025)
Figure 76. Europe Anti-diabetic Medication Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Anti-diabetic Medication Revenue Market Forecast (2021-2025)
Figure 78. South America Anti-diabetic Medication Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Anti-diabetic Medication Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel

---